The Association between White Matter Lesions on Magnetic Resonance Imaging and Noncognitive Symptoms
about
Rivastigmine for vascular cognitive impairmentGalantamine for vascular cognitive impairmentRivastigmine for vascular cognitive impairmentGalantamine for vascular cognitive impairmentNeuroimaging of white matter in aging and dementia.Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia?Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.Neurocognitive profiles in elderly patients with frontotemporal degeneration or major depressive disorder.Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.Temporal relationships between depressive symptoms and white matter hyperintensities in older men and women.Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.Depression in cognitive impairment.Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features.Distinct cognitive phenotypes in Alzheimer's disease in older people.Relationship between depressive symptomatology and the subcortical brain syndrome in dementia.Stage-specific gender differences in cognitive and neuropsychiatric manifestations of vascular dementia.Association between subcortical lesions and behavioral and psychological symptoms in patients with Alzheimer's disease.Association of cerebral small vessel disease with delusions in patients with Alzheimer's disease.The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.
P2860
Q24202891-C01E1196-6E40-47BB-9BE6-BDBEF04FC9B2Q24244817-417A8A19-B116-4F74-8A7F-74D9FA95B793Q24247146-834A1AD5-F1B1-4022-8BF1-035C7B81B797Q24247270-7C59992B-428A-4445-BC30-625E2EC786B3Q33279055-127B00C0-4E20-421A-A03C-49596CD5032FQ33492926-5134316D-D49B-46CF-B37B-55BE9A36F30FQ34953672-5E6CA92C-01AD-4365-B7D0-8D07BFD4BDECQ35870558-66C1FC40-ECDA-4C5D-919A-E9433701D022Q37217602-EE5C753A-649C-4524-9FC7-81C3D72B4D5DQ37364541-765313FF-0A7D-46AE-B95F-3B3AA6EBEBE9Q37445941-4246D4B6-039D-4443-A9E8-3F45074D5835Q37608839-9981A05C-3642-4FD1-A1A6-FB10E423EE9CQ39709239-DF87620F-688F-4391-A60B-F44A64BE803DQ46122745-2BD810A0-31EF-4B11-B301-CB13C8214E0CQ48493751-0AB555CC-2719-4FC1-BD27-50A70F7CED8DQ48620539-C9F739E9-6B30-49C3-87F3-3FA29D80C19BQ48654934-C4BB57F7-7A9B-42DF-96D8-550CD2963861Q48717765-ACB3C1A8-936B-4C2E-ADAC-CB90ED5C3DCEQ53322019-E63B202B-FD2F-4F1B-9468-84B3F5BC447A
P2860
The Association between White Matter Lesions on Magnetic Resonance Imaging and Noncognitive Symptoms
description
article
@en
im April 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2000
@uk
name
The Association between White ...... ging and Noncognitive Symptoms
@en
The Association between White ...... ging and Noncognitive Symptoms
@nl
type
label
The Association between White ...... ging and Noncognitive Symptoms
@en
The Association between White ...... ging and Noncognitive Symptoms
@nl
prefLabel
The Association between White ...... ging and Noncognitive Symptoms
@en
The Association between White ...... ging and Noncognitive Symptoms
@nl
P2093
P2860
P1476
The association between white ...... ging and noncognitive symptoms
@en
P2093
P2860
P304
P356
10.1111/J.1749-6632.2000.TB06403.X
P433
1 VASCULAR FACT
P577
2000-04-01T00:00:00Z